Dave Amerson – Board Member, Intrinsic Therapeutics, Inc 

Emily Blum, MD – CMO at Harbright Ventures

Karthik Bolisetty – Investment Manager, Gilde Healthcare Partners

Gerry Brunk – Managing Director, Lumira Ventures

John Calicchio – President & CEO, ICON Capital Group, LLC

Thomas Cherry – Senior Director, Global Business Development, Cook Medical

Sean Coyer – Director of Growth Strategy, Calyxo

Chris Cutie, MD – Disease Area Stronghold Leader, Bladder Cancer, Johnson & Johnson Innovative Medicine

Jeff Dann – President, J. Dann Consulting

Alana Darden Powell – Vice President, Marketing, Sumitomo Pharma America

Jonathan Demchick – Principal at Gilmartin Capital

Ryan Drant – Founder and Managing Partner, Questa Capital

Matthew Dumont – Sr. Director, Urology Business Development, Boston Scientific

Kevin Eisenfrats – Co-Founder & CEO at Contraline Inc.

Dean Elterman, MD – CMO at MedTech Syndicates

Sergio Gatoulis – Senior Medical Director, Bladder Cancer, Pfizer

Deborah Hemingway, PhD – Founder & Managing Partner at Ecphora Capital

Justin Kirkpatrick – Partner, Questa Capital

Ted Lamson – Founder, NeoTract

John Leachman – Partner, Harbright Ventures

Gavin Leonard – Founder & CEO, MedTech Syndicates

Howard Levin, MD – Managing Partner & Chief Medical Officer, Coridea, LLC

Dave Perry – CEO, Verve Medical

Bryan Pinchuk – CEO at Innocare Neurologics

Shai Policker – Managing Partner, Edge Medical Ventures

James Ramey, JD – Managing Director & GP, VTC Ventures

Chris Rowland – Founder & Managing Partner, KWGB Partners, LLC

Emir Sandhu, MD – Managing Director, Sandbox Industries

Mark Schoenberg, MD – Chief Medical Officer, Urogen Pharma

Mark Stevenson – COO, MedTech Syndicates

Armen Vidian – Co-Managing Partner & Co-Founder at Recode Ventures

Jennie Xue – Managing Director, Goldman Sachs